Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study

Dupilumab efficacy in uncontrolled, moderate-to-serve allergic asthma in the phase 3 liberty asthma quest study

書誌詳細
主要な著者:	Castro, M, Corren, J, Hanania, N, Pavord, I, Quirce, S, Thangavelu, K, Rice, M, O'Riordan, T, Maroni, J, Rowe, P, Lu, Y, Amin, N, Ruddy, M, Akinlade, B, Graham, N, Teper, A
フォーマット:	Conference item
出版事項:	Elsevier 2018

類似資料

Dupilumab reduces severe exacerbation rate and improves lung function in adolescent patients with uncontrolled, moderate-to-severe asthma: from the Liberty Asthma Quest study
著者:: Maspero, J, 等
出版事項: (2018)

A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma
著者:: Castro, M, 等
出版事項: (2018)

Dupilumab reduces risk of severe exacerbations and improves FEV1 in patients on both high- and medium dose ICS with uncontrolled, moderate-to-severe asthma from the phase 3 LIBERTY ASTHMA QUEST Study
著者:: Pavord, I, 等
出版事項: (2018)

Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST
著者:: Wenzel, SE, 等
出版事項: (2018)

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
著者:: Mario Castro, 等
出版事項: (2020-01-01)

Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study
著者:: Yuji Tohda, 等
出版事項: (2020-10-01)

Liberty asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy/safety in patients with uncontrolled, moderate-to-severe asthma
著者:: Busse, WW, 等
出版事項: (2018)

Dupilumab efficacy and safety in moderate-to-severe uncontrolled Asthma
著者:: Castro, M, 等
出版事項: (2018)

Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
著者:: Sung-Hee Oh, 等
出版事項: (2024-08-01)

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis
著者:: Maspero, JF, 等
出版事項: (2019)

Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
著者:: Guilbert TW, 等
出版事項: (2024-03-01)

Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study
著者:: Yuji Tohda, 等
出版事項: (2023-01-01)

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
著者:: Corren J, 等
出版事項: (2023-03-01)

Azithromycin in uncontrolled asthma
著者:: Brusselle, G, 等
出版事項: (2017)

Dupilumab in the management of moderate-to-severe asthma: the data so far
著者:: Barranco P, 等
出版事項: (2017-09-01)

Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
著者:: Lucia De Prado Gomez, 等
出版事項: (2023-03-01)

Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review
著者:: Evelyn Evelyn, 等
出版事項: (2022-11-01)

Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
著者:: Busse WW, 等
出版事項: (2023-04-01)

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation
著者:: Hanania NA, 等
出版事項: (2022-06-01)

Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthma
著者:: Jonathan Corren, 等
出版事項: (2023-10-01)

Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils
著者:: Eugene R. Bleecker, 等
出版事項: (2023-01-01)

Efficacy and safety of dupilumab for the treatment of uncontrolled asthma: a meta-analysis of randomized clinical trials
著者:: Xiao-feng Xiong, 等
出版事項: (2019-05-01)

The Role of Dupilumab in Severe Asthma
著者:: Fabio Luigi Massimo Ricciardolo, 等
出版事項: (2021-08-01)

Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma
著者:: Gurnell M, 等
出版事項: (2024-01-01)

Bronchial thermoplasty and biological therapy as targeted treatments for severe uncontrolled asthma
著者:: Trivedi, A, 等
出版事項: (2016)

A Case of Uncontrolled Asthma
著者:: Ömür Aydin M.D., 等
出版事項: (2011-04-01)

Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function
著者:: Pavord ID, 等
出版事項: (2020-12-01)

Experience of using dupilumab in the treatment of severe asthma
著者:: G. L. Ignatova, 等
出版事項: (2020-09-01)

Controversies in allergy: should severe asthma with eosinophilic phenotype always be treated with anti-IL-5 therapies
著者:: Pavord, I, 等
出版事項: (2019)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
著者:: Laidlaw TM, 等
出版事項: (2023-09-01)

Dupilumab-associated hypereosinophilia in severe asthma
著者:: April Strong, 等
出版事項: (2024-07-01)

Severe pediatric asthma therapy: Dupilumab
著者:: Giuliana Ferrante, 等
出版事項: (2022-11-01)

Dupilumab: a novel treatment for asthma
著者:: Vatrella A, 等
出版事項: (2014-09-01)

Efficacy of asthma education program on asthma control in children with uncontrolled asthma
著者:: Zeynep Arıkan-Ayyıldız, 等
出版事項: (2016-08-01)

Repeated exacerbation of asthma: An intrinsic phenotype of uncontrolled asthma
著者:: Neeraj Jain, 等
出版事項: (2019-01-01)

Socio-psychological problems in adolescents with uncontrolled bronchial asthma
著者:: L. S. Evert, 等
出版事項: (2025-01-01)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
著者:: Laidlaw TM, 等
出版事項: (2023-09-01)

UNCONTROLLED BRONCHIAL ASTHMA IN CHILDREN
著者:: L.S. Namazova-Baranova
出版事項: (2009-08-01)

UNCONTROLLED BRONCHIAL ASTHMA IN CHILDREN
著者:: L.S. Namazova-Baranova
出版事項: (2009-08-01)

Efficacy of tezepelumab against uncontrolled severe non‐type 2 asthma refractory to bronchial thermoplasty, benralizumab, dupilumab and mepolizumab
著者:: Yoshiro Kai, 等
出版事項: (2024-03-01)